Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kent

Showing results (951-960 of 1,017) with videos related to

Pageof 102
Sort By:
Nature Medicine|July 15, 2020
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19Jennifer A Juno, Hyon-Xhi Tan, Wen Shi Lee, et al.
Human Gene Therapy|July 21, 2018
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope VaccineHannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, et al.
Nature Communications|April 17, 2024
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infectionChansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonistsYong Gong, J Kent Barbay, Alexey B Dyatkin, et al.
NPJ Vaccines|November 28, 2025
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responsesVeronica P Zoest, Wen Shi Lee, Lydia Murdiyarso, et al.
Immunology and Cell Biology|September 19, 2023
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19Wuji Zhang, E Bridie Clemens, Lukasz Kedzierski, et al.
ACS Nano|June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA VaccineYi Ju, Wen Shi Lee, Emily H Pilkington, et al.
Journal of Medicinal Chemistry|January 14, 2012
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's diseaseBrian C Shook, Stefanie Rassnick, Nathaniel Wallace, et al.
EMBO Molecular Medicine|March 10, 2026
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccinationWuji Zhang, E Kaitlynn Allen, Shihan Li, et al.
Immunity|March 23, 2023
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responsesMarios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Pageof 102

Showing results (951-960 of 1,017) with videos related to

Sort By:
Pageof 102
Nature Medicine|July 15, 2020
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19Jennifer A Juno, Hyon-Xhi Tan, Wen Shi Lee, et al.
Human Gene Therapy|July 21, 2018
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope VaccineHannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, et al.
Nature Communications|April 17, 2024
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infectionChansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonistsYong Gong, J Kent Barbay, Alexey B Dyatkin, et al.
NPJ Vaccines|November 28, 2025
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responsesVeronica P Zoest, Wen Shi Lee, Lydia Murdiyarso, et al.
Immunology and Cell Biology|September 19, 2023
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19Wuji Zhang, E Bridie Clemens, Lukasz Kedzierski, et al.
ACS Nano|June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA VaccineYi Ju, Wen Shi Lee, Emily H Pilkington, et al.
Journal of Medicinal Chemistry|January 14, 2012
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's diseaseBrian C Shook, Stefanie Rassnick, Nathaniel Wallace, et al.
EMBO Molecular Medicine|March 10, 2026
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccinationWuji Zhang, E Kaitlynn Allen, Shihan Li, et al.
Immunity|March 23, 2023
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responsesMarios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Pageof 102